Identification of genomic regions that confer susceptibility to or protection from major depressive disorder (MDD) via genomewide association. Consent groups and participant set <ul> <li>Psychiatric and Related Somatic Conditions (PRSC): 3741 (1821 cases, 1822 controls, 98 others)</li> </ul>

Major Depression: Stage 1 Genomewide Association in Population-Based    Samples

Depressive Disorder, Major study with SNP Genotypes (Array) data on dbGaP (3,741 participants)